Letter to the Editor

Journal of Immunological Methods

Volumn 318, Issue 1-2, 2007, Pages 158-159

  Özdemir, Öner ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEDIATED CYTOTOXICITY; CYTOTOXICITY TEST; FLOW CYTOMETRY; HUMAN; IMMUNOASSAY; LABORATORY TEST; LETTER; NATURAL KILLER CELL; PRIORITY JOURNAL;

EID: 33846027151     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2006.09.001     Document Type: Letter

References (8)

1. Aubry J.P., Blaecke A., Lecoanet-Henchoz S., Jeannin P., Herbault N., Caron G., Moine V., and Bonnefoy J.Y. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry 37 (1999) 197
2. Godoy-Ramirez K., Franck K., and Gaines H. A novel method for the simultaneous assessment of natural killer cell conjugate formation and cytotoxicity at the single-cell level by multi-parameter flow cytometry. J. Immunol. Methods 239 (2000) 35
3. Langhans B., Ahrendt M., Nattermann J., Sauerbruch T., and Spengler U. Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays. J. Immunol. Methods 306 (2005) 161
4. Özdemir Ö., and Savaşan S. Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine activated killer cell cytotoxicity against human leukemia/lymphoma cells. Clin. Immunol. 115 (2005) 240
5. Özdemir Ö., Ravindranath Y., and Savasan S. Cell-mediated cytotoxicity evaluation using monoclonal antibody staining for target or effector cells with annexinV/propidium iodide colabeling by fluorosphere-adjusted counts on three-color flow cytometry. Cytometry A 56 (2003) 53
6. Özdemir Ö., Ravindranath Y., and Savaşan S. Mechanisms of superior anti-tumor cytotoxic response of Interleukin-15-induced lymphokine-activated killer cells. J. Immunother. 28 (2005) 44
7. Robertson M.J., Cochran K.J., Cameron C., Le J.M., Tantravahi R., and Ritz J. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia. Exp. Hematol. 24 (1996) 406
8. Shafer-Weaver K., Sayers T., Strobl S., Derby E., Ulderich T., Baseler M., and Malyguine A. The Granzyme B ELISPOT assay: an alternative to the 51Cr-release assay for monitoring cell-mediated cytotoxicity. J. Transl. Med. 1 (2003) 14